Meyer Vitabiotics, a leading pharmaceutical manufacturer, has conducted a groundbreaking study demonstrating the potential of antioxidant micronutrients and vitamins in improving male fertility. The research involved 300 Indian males with varying types and degrees of infertility, and tested the effectiveness of Oligocare Forte Plus, a supplement containing multi-vitamins, minerals, essential amino acids, ginseng, and lycopene. Results showed a 75.76% increase in sperm count among males with a baseline sperm count of less than 5 million/ml.
Male infertility is a significant global concern, with existing treatment options often associated with higher costs, uncertain clinical effectiveness, and side effects. The study offers a new perspective on male infertility treatment, showcasing the potential of antioxidant micronutrient therapy as a more accessible, cost-effective, and clinically efficient alternative to current options.
The Oligocare Forte Plus tablet, also known as Wellman Conception in the UK, combines essential micronutrients, amino acids, antioxidants, and vitamins crucial for male reproductive health. Meyer Vitabiotics’ groundbreaking research offers hope for millions of men worldwide who suffer from male factor infertility, providing valuable insights into the impact of antioxidant therapy on improving semen parameters and the DNA Fragmentation Index (DFI).